Azitra Inc(AZTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AZTR Azitra Inc

Halted 10-15 13:15:15 EDT

0.0715

+0.0000

0.00%

High0.0715	Low0.0715	Vol0.00
Open0.0715	D1 Closing0.0715	Amplitude0.00%
Mkt Cap4.33M	Tradable Cap3.66M	Total Shares60.60M
T/O0.00	T/O Rate0.00%	Tradable Shares51.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AZTR","market":"US","secType":"STK","nameCN":"Azitra Inc","latestPrice":0.0715,"timestamp":1792084515794,"preClose":0.0715,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":51252299,"shares":60603700,"eps":-1.3022,"marketStatus":"Halted","change":0,"latestTime":"10-15 13:15:15 EDT","open":0.0715,"high":0.0715,"low":0.0715,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.3022,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792094400000},"marketStatusCode":2,"adr":0,"listingDate":1684382400000,"exchange":"AMEX","adjPreClose":0.0715,"volumeRatio":0},"requestUrl":"/m/hq/s/AZTR/tweets","defaultTab":"tweets","newsList":[{"id":"2672547677","title":"Azitra Advances ATR-04 Phase 1/2 Trial to Cohort 2 After Safety Review Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672547677","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672547677?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:03","pubTimestamp":1790856192,"startTime":"0","endTime":"0","summary":"Azitra advances ATR-04 Phase 1/2 trial to Cohort 2 after safety review clearanceAzitra cleared Cohort 1 in a Phase 1/2 trial of topical ATR04-484 for EGFR inhibitor-associated skin rash.Safety data fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL40h0FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672575410","title":"Azitra, Inc. Advances Atr-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672575410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672575410?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:00","pubTimestamp":1790856010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA96JYVJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671504762","title":"Azitra Enters $3.5 Million At-the-Market Equity Distribution Agreement with A.G.P","url":"https://stock-news.laohu8.com/highlight/detail?id=2671504762","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671504762?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:50","pubTimestamp":1790628659,"startTime":"0","endTime":"0","summary":"Azitra enters $3.5 million at-the-market equity distribution agreement with A.G.PAzitra entered an at-the-market sales agreement with A.G.P./Alliance Global Partners to sell up to USD 3.5 million of c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL6Gnp8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250452","title":"Azitra - May Offer Common Stock up to $3.50 Mln Through A.g.p. - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250452?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:47","pubTimestamp":1790628426,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0DQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665595320","title":"Azitra COO Travis Whitfill Presents at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665595320","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665595320?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868891,"startTime":"0","endTime":"0","summary":"Azitra COO Travis Whitfill presents at H.C. Wainwright Global Investment ConferenceAzitra will present virtually at the H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7TzlBP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661609442","title":"Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2661609442","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661609442?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:00","pubTimestamp":1787313605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nTUA6GKPMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483013","title":"Azitra reports Q2 EPS (17c) vs. ($1.18) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483013","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483013?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:41","pubTimestamp":1786956110,"startTime":"0","endTime":"0","summary":"“The second quarter has marked an exciting evolution for Azitra (AZTR) with the first data from our ATR-COSF program, which provided validation of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/azitra-reports-q2-eps-17c-vs-1-18-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/azitra-reports-q2-eps-17c-vs-1-18-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183875","title":"Anitra Q2 EPS $(0.17) Misses $(0.12) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183875","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183875?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:02","pubTimestamp":1786568543,"startTime":"0","endTime":"0","summary":"Anitra (AMEX:AZTR) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.12) by 54.55 percent. This is a 85.95 percent increase over losses of $(1.21) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61161482/anitra-q2-eps-0-17-misses-0-12-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Anitra Q2 EPS $(0.17) Misses $(0.12) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659887491","title":"Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659887491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659887491?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA5HL1LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659518824","title":"Azitra Q2 FY26 Net Loss Widens to $3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659518824","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659518824?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:56","pubTimestamp":1786568173,"startTime":"0","endTime":"0","summary":"Azitra Q2 FY26 net loss widens to $3.3 millionAzitra posted a net loss of USD 3.3 million for the quarter ended June 30, 2026, widening from USD 2.9 million a year earlier.G&A expenses climbed to USD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL24CRHr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651950104","title":"Azitra - Single Dose Ex Vivo Study Shows Improved Elasticity and Reduced Wrinkles - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651950104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651950104?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:21","pubTimestamp":1784146915,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H1JL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495064","title":"Azitra - Announces Breakthrough Ex Vivo Results for Atr-cosf Program - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651495064?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:21","pubTimestamp":1784146915,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H1JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449501","title":"Azitra - Ex Vivo Data Shows Increased Rhdfilaggrin Distribution in Human Skin - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651449501?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:21","pubTimestamp":1784146915,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H1JL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651218469","title":"Azitra Posts Ex Vivo Anti-wrinkle, Repeat-dose Distribution Gains for Atr-cosf Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2651218469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651218469?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:11","pubTimestamp":1784124665,"startTime":"0","endTime":"0","summary":"Azitra posts ex vivo anti-wrinkle, repeat-dose distribution gains for ATR-COSF programAzitra reported ex vivo repeat-dose results for its ATR-COSF cosmetic program showing increased delivery of rHDfil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL5M24PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644063590","title":"Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?","url":"https://stock-news.laohu8.com/highlight/detail?id=2644063590","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644063590?lang=en_us&edition=fundamental","pubTime":"2026-06-19 15:06","pubTimestamp":1781852760,"startTime":"0","endTime":"0","summary":"Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and upcoming biotech presentation plans.","market":"nz","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/06/19/Trading-Investment-Charts--Investment-Fi.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/06/19/Trading-Investment-Charts--Investment-Fi.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/26/06/60000312/why-did-azitra-aztr-stock-jump-over-25-after-hours","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/06/60000312/why-did-azitra-aztr-stock-jump-over-25-after-hours","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["AZTR","RSI","BK4139","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745987","title":"Azitra says shareholder letter is available","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745987","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745987?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:02","pubTimestamp":1781697763,"startTime":"0","endTime":"0","summary":"Azitra announced the availability of a shareholder letter from CEO Francisco Salva outlining a strategic reorientation toward nearer-term milestones.Letter cites March financing of $10.5 million, with up to an additional $21 million tied to warrant exercises.Plans ATR-COSF recombinant filaggrin cosmetic ingredient program; targets fine lines and wrinkles; clinical study completion expected late 2026.Expands into recombinant proteins using in-licensed FHCC technologies; initial focus on TEV protease, T7 RNA polymerase; partnership or commercialization targeted within 36 months.ATR-04 trial for EGFR inhibitor-associated rash continues enrollment; ATR-12 Netherton syndrome enrollment paused to conserve capital.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4YrBk4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644451617","title":"Azitra - to Pause Further Enrollment in Atr-12 Trial to Redirect Funds to Atr-Cosf","url":"https://stock-news.laohu8.com/highlight/detail?id=2644451617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644451617?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA57VSKH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644274552","title":"Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2644274552","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644274552?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA57VSKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644487717","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644487717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644487717?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:08","pubTimestamp":1781694484,"startTime":"0","endTime":"0","summary":"Eshallgo  shares were up 296% in Wednesday premarket activity, adding to gains from the previous session.Azitra  shares were up 93% after the company said it will present updates on its pipeline, including a protein and peptide program for the cosmetic and cosmeceutical markets, at an upcoming conference.J-Star  stock was up 86% after a 37% decline in the previous session.Lunai Bioworks  stock was up 79%, continuing from Tuesday's 9% gain.Tianci International  shares were up 43%, recovering from the previous session's 70% decline","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZTR","CIIT","YMAT","EHGO","BK4021","BK4139","LNAI","BK4143","BK4190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793336","title":"Azitra COO Whitfill presents at BIO International Convention","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793336?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:29","pubTimestamp":1781645368,"startTime":"0","endTime":"0","summary":"Azitra will present at the BIO International Convention in San Diego on June 23, 2026 at 4:45 PM PT.Cofounder and COO Travis Whitfill will outline pipeline progress, including a protein and peptide program leveraging filaggrin technology for cosmetics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3KGNtl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.azitrainc.com","stockEarnings":[{"period":"1week","weight":-0.4583},{"period":"1month","weight":-0.5926},{"period":"3month","weight":-0.4616},{"period":"6month","weight":-0.6673},{"period":"1year","weight":-0.9053},{"period":"ytd","weight":-0.73}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0115},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0837},{"period":"1year","weight":0.1621},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.067983},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.19875},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.00274},{"month":4,"riseRate":1,"avgChangeRate":0.06636},{"month":5,"riseRate":0,"avgChangeRate":-0.125233},{"month":6,"riseRate":0,"avgChangeRate":-0.274455},{"month":7,"riseRate":0.25,"avgChangeRate":-0.301215},{"month":8,"riseRate":0.25,"avgChangeRate":-0.110026},{"month":9,"riseRate":0,"avgChangeRate":-0.241202},{"month":10,"riseRate":0,"avgChangeRate":-0.203808},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.177131},{"month":12,"riseRate":0,"avgChangeRate":-0.200843}],"exchange":"AMEX","name":"Azitra Inc","nameEN":"Azitra Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Azitra Inc(AZTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Azitra Inc(AZTR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Azitra Inc,AZTR,Azitra Inc股票,Azitra Inc股票老虎,Azitra Inc股票老虎国际,Azitra Inc行情,Azitra Inc股票行情,Azitra Inc股价,Azitra Inc股市,Azitra Inc股票价格,Azitra Inc股票交易,Azitra Inc股票购买,Azitra Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Azitra Inc(AZTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Azitra Inc(AZTR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction